ANTIBODY TO LILRB2

To provide an anti-LILRB2 antibody that can be used in a method for treating a disease such as cancer.SOLUTION: An antibody specifically binds to human LILRB2, where the antibody includes six complementarity determining regions (CDR) of (a) CDR-H1, (b) CDR-H2, (c) CDR-H3, (d) CDR-L1, (e) CDR-L2, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YASMIN RAMSAY, HEATHER B COHEN, DONALD RAYMOND SHAFFER, LAUREN PEPPER MACKENZIE, KEVIN PATRICK GUAY, KRISTIN SHANEA O'MALLEY, JEFFREY YAN-FEI SMITH
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!